This article needs additional citations for verification. (March 2009) |
The Texas A&M Institute for Genomic Medicine (TIGM) is a research institute of Texas A&M AgriLife Research. It was founded in 2005 under a $50 million award from the Texas Enterprise Fund to accelerate the pace of medical discoveries and foster the development of the biotechnology industry in Texas.
| Established | 2005 |
|---|---|
| Focus | biotechnology |
| Location |
TIGM helps researchers gain faster access to the genetically engineered knockout mice used in medical research. TIGM owns and maintains the world's largest library of embryonic stem cells for C57BL/6 mice. In addition, TIGM has contracted access to the world's largest library of genetically modified 129 mouse cells. The Institute headquarters and laboratory facilities are based on the main campus of Texas A&M University in College Station, Texas.[1]